Transplante – Medula Óssea
5 principais desafios da gestão de antibióticos em doenças infecciosas relacionadas a transplante e estratégias práticas para abordá-las.
2 Mai, 2022 | 13:55h
Comentário no Twitter
🆕💥Review Article @ASHE_Journal
Bring it on: Top five antimicrobial stewardship challenges in transplant infectious diseases and practical strategies to address them #IDTwitter #medtwitter #TwitteRx #MedEd https://t.co/ToPLQXtC4r pic.twitter.com/pZQWWb3ZSx— Antibiotic Steward Bassam Ghanem🆔🔥 (@ABsteward) April 28, 2022
Sob licença de http://creativecommons.org/licenses/by/4.0/
Índice de estresse e ativação endotelial (EASIX – endothelial activation and stress index) pré-transplante pode predizer danos causados por sepse após transplante alogênico de células-tronco.
21 Abr, 2022 | 11:30hPre-transplant EASIX and sepsis after allogeneic stem cell transplantation – Intensive Care Medicine
Comentário no Twitter
🧪 Endothelial complications major causes of mortality post alloSCT. Pre Tx Endothelial Activation & Stress IndeX EASIX (basic lab data characterizing Tx-associated thrombotic microangiopathy) powerful marker of #sepsis, dysfunctional endothelial response.https://t.co/FRGUGT8L78 pic.twitter.com/VF2wTLCHaM
— Intensive Care Medicine (@yourICM) April 18, 2022
Um estudo de braço único avaliou o uso de enxerto de células-tronco do sangue periférico com depleção de células T naive para prevenir a doença enxerto-versus-hospedeiro crônica.
20 Jan, 2022 | 21:48hNaive T-Cell Depletion to Prevent Chronic Graft-Versus-Host Disease – Journal of Clinical Oncology
Comentário: New graft strategy may improve outcomes for blood stem cell recipients – University of Pittsburg
Estudo randomizado | Maribavir para infecções por citomegalovírus refratárias com ou sem resistência pós-transplante.
7 Dez, 2021 | 11:29hDiretrizes ASH 2021 para transplante de célula-tronco em pacientes com doença falciforme.
14 Out, 2021 | 10:43hComunicado de imprensa: ASH Releases New Clinical Practice Guidelines on Stem Cell Transplantation in Sickle Cell Disease
Comentário: ASH Issues Guideline on the Use of HSCT for Sickle Cell Disease – HealthDay
FDA autoriza aplicação de dose adicional da vacina contra Covid-19 em indivíduos imunocomprometidos – As demais pessoas, já plenamente vacinadas, não precisam de dose adicional neste momento.
16 Ago, 2021 | 12:10hComentários:
CDC, FDA recommend COVID booster for immune-compromised – CIDRAP
FDA authorizes additional dose of Covid-19 vaccine for the immunocompromised – STAT
Covid booster: US approves third jab for the immunocompromised – BBC
CDC Panel Recommends 3rd Vaccine Dose For Immunocompromised People – NPR
6 Things To Know If You’re Immunocompromised And Considering A 3rd Shot – NPR
CDC recommends third Covid-19 vaccine dose for certain immunocompromised people – CNN
Comentário no Twitter
The Infectious Diseases Society of America (IDSA) supports the @FDA and @CDCgov's decision to authorize a supplemental vaccine dose for immunocompromised patients.
Read our statement: https://t.co/odzzSgIxnY pic.twitter.com/4PZfUwpjhM
— IDSA (@IDSAInfo) August 13, 2021